{
  "ticker": "FGEN",
  "company_name": "FibroGen, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03960489",
      "title": "A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Adult Subjects",
      "start_date": "2019-07-31",
      "completion_date": "2019-10-14",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Global Development, Inc."
    },
    {
      "nct_id": "NCT02964936",
      "title": "A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Chronic Kidney Disease",
      "start_date": "2017-01-11",
      "completion_date": "2018-08-15",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Inc"
    },
    {
      "nct_id": "NCT01147666",
      "title": "Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "End Stage Renal Disease, Anemia",
      "start_date": "2010-05-17",
      "completion_date": "2012-10-15",
      "enrollment": 0,
      "sponsor": "FibroGen"
    },
    {
      "nct_id": "NCT05011188",
      "title": "FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Castration-resistant Prostate Cancer, Prostate Cancer",
      "start_date": "2022-01-19",
      "completion_date": "2027-07-31",
      "enrollment": 0,
      "sponsor": "Rahul Aggarwal"
    },
    {
      "nct_id": "NCT02161796",
      "title": "A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "PK for FG-4592, Healthy Subjects",
      "start_date": "2013-09",
      "completion_date": "2013-12",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Europe B.V."
    },
    {
      "nct_id": "NCT01244763",
      "title": "Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Kidney Disease, Anemia",
      "start_date": "2010-10-29",
      "completion_date": "2012-06-13",
      "enrollment": 0,
      "sponsor": "FibroGen"
    },
    {
      "nct_id": "NCT02021318",
      "title": "Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Anemia in Chronic Kidney Disease in Non-dialysis Patients",
      "start_date": "2014-03-12",
      "completion_date": "2019-11-06",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Europe B.V."
    },
    {
      "nct_id": "NCT02988973",
      "title": "A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Chronic Kidney Disease",
      "start_date": "2017-01-12",
      "completion_date": "2020-03-26",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Inc"
    },
    {
      "nct_id": "NCT02693613",
      "title": "Pharmacokinetic Study of ASP1517 With Kremezin\u00ae",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2016-02",
      "completion_date": "2016-04",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Inc"
    },
    {
      "nct_id": "NCT02952040",
      "title": "A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Subjects",
      "start_date": "2016-11",
      "completion_date": "2016-12",
      "enrollment": 0,
      "sponsor": "Astellas Pharma Inc"
    }
  ],
  "summary": {
    "total_trials": 25,
    "by_phase": {
      "PHASE1": 8,
      "PHASE3": 10,
      "PHASE2": 6,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "COMPLETED": 23,
      "ACTIVE_NOT_RECRUITING": 1,
      "TERMINATED": 1
    },
    "active_trials": 1,
    "completed_trials": 23,
    "conditions": [
      "Anemia in Chronic Kidney Disease in Non-dialysis Patients",
      "Anemia, End Stage Renal Disease (ESRD)",
      "Chemotherapy Induced Anemia",
      "Chronic Kidney Disease",
      "Chronic Kidney Disease, Anemia",
      "Chronic Kidney Disease, End Stage Renal Disease, Anemia",
      "Dialysis, Anemia",
      "ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia",
      "End Stage Renal Disease, Anemia",
      "Healthy Adult Subjects",
      "Healthy Subjects",
      "Healthy Volunteers",
      "Hemodialysis Chronic Kidney Disease Patients With Anemia",
      "Hemodialysis Patients With Renal Anemia",
      "Metastatic Castration-resistant Prostate Cancer, Prostate Cancer",
      "Normal Renal Function, Impaired Renal Function",
      "PK for FG-4592, Healthy Subjects",
      "PK of FG-4592, Hepatic Insufficiency, Healthy Subjects",
      "Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia",
      "Pharmacokinetics of FG-4592, Healthy Subjects",
      "Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts), Anemia"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:44:06.994860",
    "search_query": "FibroGen, Inc.",
    "url": "https://clinicaltrials.gov/search?term=FibroGen,+Inc."
  }
}